What if you invested $1000 in VTRS on Jan 1, 2020?
Explore hypothetical investment results for stocks, ETFs, and more. See real historical data and share your discoveries.
Historical Annual Returns
Over the past 20 years, Viatris Inc. has delivered an average annual return of 1.4%. The stock peaked in 2009 with a massive +83.9% gain, while investors faced a downturn in 2018 (-36.4%). Overall, the stock finished in the green 9 times out of 20 years.
Avg Return
+1.4%
Win Rate
45%
9W - 11L
Best
+83.9%
2009
Worst
-36.4%
2018
Performance Consistency
About Viatris Inc.
Visit Website ↗Viatris is a global healthcare company formed by the merger of Mylan and Upjohn (a division of Pfizer). It provides access to high-quality medicines for patients worldwide.
Key Business Segments
Developed Markets
Sales in North America and Europe.
Emerging Markets
Sales in Asia, Latin America, and Africa.
JANZ
Sales in Japan, Australia, and New Zealand.
Key Innovations
- ✓Biosimilars portfolio
- ✓Global supply chain for generics
Historical Milestones
Formed by merger of Mylan and Pfizer's Upjohn business.